Antu Eapan Thomas
Stock Analyst at Geojit Research
(1.74)
# 8,006
Out of 12,268 analysts
40
Total ratings
40%
Success rate
0.2%
Average return
Main Sectors:
Stocks Rated by Antu Eapan Thomas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: SBICARD SBI Cards and Payment Services Limited | Maintained: Buy | $950 → $698 | $629.20 | +10.93% | 2 | May 18, 2026 | |
| NSE: PVRINOX PVR INOX Limited | Maintained: Buy | $1,065 | $975.70 | +9.15% | 1 | Mar 31, 2026 | |
| NSE: LICI Life Insurance Corporation of India | Reiterated: Buy | $1,088 → $934 | $854.10 | +9.35% | 3 | Mar 18, 2026 | |
| NSE: NBCC NBCC (India) Limited | Rated: Hold | n/a | $96.61 | - | 1 | Mar 17, 2026 | |
| NSE: GODREJPROP Godrej Properties Limited | Maintained: Buy | $2,096 | $1,780.10 | +17.75% | 1 | Feb 26, 2026 | |
| NSE: AMBER Amber Enterprises India Limited | Initiated Coverage: Buy | $9,156 | $7,410.00 | +23.56% | 1 | Feb 23, 2026 | |
| NSE: HCG HealthCare Global Enterprises Limited | Upgraded: Buy | $628 → $724 | $656.00 | +10.37% | 2 | Feb 19, 2026 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Maintained: Buy | $780 | $764.65 | +2.01% | 1 | Feb 19, 2026 | |
| NSE: MAXHEALTH Max Healthcare Institute Limited | Upgraded: Buy | $1,180 | $996.75 | +18.38% | 1 | Feb 16, 2026 | |
| NSE: VEDL Vedanta Limited | Reiterated: Buy | $568 → $791 | $345.90 | +128.68% | 3 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $686 | $474.40 | +44.60% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4,409 → $4,560 | $4,043.80 | +12.77% | 2 | Feb 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $857 → $828 | $618.45 | +33.88% | 4 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2,244 → $2,080 | $1,873.90 | +11.00% | 2 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $312 → $439 | $438.00 | +0.23% | 2 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1,076 | $969.10 | +11.03% | 1 | Jan 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1,085 | $1,178.90 | -7.97% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2,254 | $1,889.20 | +19.31% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,790 → $1,613 | $1,447.30 | +11.45% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,015 | $840.00 | +20.83% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1,820 | $1,404.10 | +29.62% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,791 → $1,247 | $600.85 | +107.54% | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3,691 | $2,295.00 | +60.83% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $386 | $213.75 | +80.58% | 1 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2,770 | $740.00 | n/a | 1 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $326 | $304.00 | n/a | 1 | Dec 10, 2024 |
SBI Cards and Payment Services Limited
May 18, 2026
Maintained: Buy
Price Target: $950 → $698
Current: $629.20
Upside: +10.93%
PVR INOX Limited
Mar 31, 2026
Maintained: Buy
Price Target: $1,065
Current: $975.70
Upside: +9.15%
Life Insurance Corporation of India
Mar 18, 2026
Reiterated: Buy
Price Target: $1,088 → $934
Current: $854.10
Upside: +9.35%
NBCC (India) Limited
Mar 17, 2026
Rated: Hold
Price Target: n/a
Current: $96.61
Upside: -
Godrej Properties Limited
Feb 26, 2026
Maintained: Buy
Price Target: $2,096
Current: $1,780.10
Upside: +17.75%
Amber Enterprises India Limited
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $9,156
Current: $7,410.00
Upside: +23.56%
HealthCare Global Enterprises Limited
Feb 19, 2026
Upgraded: Buy
Price Target: $628 → $724
Current: $656.00
Upside: +10.37%
Krishna Institute of Medical Sciences Limited
Feb 19, 2026
Maintained: Buy
Price Target: $780
Current: $764.65
Upside: +2.01%
Max Healthcare Institute Limited
Feb 16, 2026
Upgraded: Buy
Price Target: $1,180
Current: $996.75
Upside: +18.38%
Vedanta Limited
Feb 11, 2026
Reiterated: Buy
Price Target: $568 → $791
Current: $345.90
Upside: +128.68%
Feb 10, 2026
Maintained: Buy
Price Target: $686
Current: $474.40
Upside: +44.60%
Feb 1, 2026
Reiterated: Buy
Price Target: $4,409 → $4,560
Current: $4,043.80
Upside: +12.77%
Jan 29, 2026
Reiterated: Buy
Price Target: $857 → $828
Current: $618.45
Upside: +33.88%
Jan 28, 2026
Maintained: Buy
Price Target: $2,244 → $2,080
Current: $1,873.90
Upside: +11.00%
Jan 2, 2026
Upgraded: Buy
Price Target: $312 → $439
Current: $438.00
Upside: +0.23%
Jan 1, 2026
Downgraded: Hold
Price Target: $1,076
Current: $969.10
Upside: +11.03%
Nov 11, 2025
Upgraded: Buy
Price Target: $1,085
Current: $1,178.90
Upside: -7.97%
Nov 10, 2025
Maintained: Buy
Price Target: $2,254
Current: $1,889.20
Upside: +19.31%
Nov 7, 2025
Maintained: Buy
Price Target: $1,790 → $1,613
Current: $1,447.30
Upside: +11.45%
Oct 31, 2025
Maintained: Buy
Price Target: $1,015
Current: $840.00
Upside: +20.83%
Oct 31, 2025
Upgraded: Buy
Price Target: $1,820
Current: $1,404.10
Upside: +29.62%
Oct 8, 2025
Reiterated: Buy
Price Target: $1,791 → $1,247
Current: $600.85
Upside: +107.54%
Jul 15, 2025
Reiterated: Buy
Price Target: $3,691
Current: $2,295.00
Upside: +60.83%
Jun 9, 2025
Maintained: Buy
Price Target: $386
Current: $213.75
Upside: +80.58%
Apr 2, 2025
Maintained: Hold
Price Target: $2,770
Current: $740.00
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: $326
Current: $304.00
Upside: n/a